Savara Inc — Director's Dealing 2017

Jan 23, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mast Therapeutics, Inc. (MSTX)
CIK: 0001160308
Period of Report: 2017-01-20

Reporting Person: Roberts Brandi (Chief Financial Officer & SVP)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-20	Restricted Stock Units	$	A	889926	Acquired		Common Stock (889926)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).